Abstract:Key Points Macrophage-stimulating protein (MSP; also known as MST1 and hepatocye growth factor-like (HGFL)), is a serum-derived growth factor that activates the RON receptor tyrosine kinase. RON signalling is essential for the survival of embryos during the peri-implantation period. Cancer cells use MSP–RON signalling for survival, migration, angiogenesis and chemoresistance, which has pathogenic implications. Crystal structure analyses have shown that a central cleft harbouring three amino acid residues in the putative catalytic site of the MSP β-chain interacts with an interface created by two RON semaphorin (SEMA) domains. This supports a model in which one MSP molecule binds two RON molecules to cause receptor dimerization and activation. Aberrant RON activation, which is induced by overexpression of protein and the generation of oncogenic isoforms and is indicated by the persistent activation of multi-intracellular signalling cascades, occurs in various types of cancers. RON signalling is also necessary for cancer cell growth and survival. These features render RON as a drug target for cancer therapy. MSP–RON signalling activates two classical signalling pathways, RAS–ERK and PI3K–AKT, both of which interact with various other pathways to create a complex signalling network. RON also crosstalks with other receptor tyrosine kinases and viral oncoproteins. Such intricate interactions highlight the importance of RON signalling in cancer pathogenesis. Overexpression of RON in primary tumours such as colon and breast cancer is predictive of patient survival and correlates with clinical and pathological parameters. Studies from mouse xenograft models have revealed that inhibition of RON by tyrosine kinase inhibitors and monoclonal antibodies blocks tumour growth. However, combinations with chemoagents achieve maximum therapeutic benefit. The tyrosine kinase inhibitor BMS-777607 and the RON-specific antibody narnatumab are currently in Phase I clinical trials.

Ribosomal Protein S6 Kinase (RSK)-2 As a Central Effector Molecule in RON Receptor Tyrosine Kinase Mediated Epithelial to Mesenchymal Transition Induced by Macrophage-Stimulating Protein

Mechanisms of RON-mediated Epithelial-Mesenchymal Transition in MDCK Cells Through the MAPK Pathway

MSP–RON signalling in cancer: pathogenesis and therapeutic potential

Inhibition of MSP-RON Signaling Pathway in Cancer Cells by a Novel Soluble Form of RON Comprising the Entire Sema Sequence.

Collaborative Activities of Macrophage-Stimulating Protein and Transforming Growth Factor- Β 1 in Induction of Epithelial to Mesenchymal Transition: Roles of the RON Receptor Tyrosine Kinase

Alterations in a Defined Extracellular Region of the RON Receptor Tyrosine Kinase Promote RON-mediated Motile and Invasive Phenotypes in Epithelial Cells.

Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Oncogenesis of RON Receptor Tyrosine Kinase： a Molecular Target for Malignant Epithelial Cancers

Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo

MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity

Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.

The MSP‐RON Pathway Regulates Liver Fibrosis Through Transforming Growth Factor Beta‐dependent Epithelial–mesenchymal Transition

Data from Ribosomal S6 Kinase 2 is a Key Regulator in Tumor Promoter–Induced Cell Transformation

β-Arrestin-1-dependent activation of extracellular signal-regulated kinases in RON receptor-mediated tumorigenic activities in colon cancer cells

Receptor tyrosine kinase RON and tumor

Pathogenesis Of Ron Receptor Tyrosine Kinase In Cancer Cells: Activation Mechanism, Functional Crosstalk, And Signaling Addiction

Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets.

Ron Expression Mediates Lipopolysaccharide-Mediated Dendritic Cell Maturation Via March-I

RON and C-Met Facilitate Metastasis Through the ERK Signaling Pathway in Prostate Cancer Cells.

The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome

A network map of macrophage-stimulating protein (MSP) signaling